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Abstract
Interaction of the cell adhesion molecule L1 with the cytoskeletal adaptor ankyrin is essential for 
topographic mapping of retinal ganglion cell (RGC) axons to synaptic targets in the superior 
colliculus (SC). Mice mutated in the L1 ankyrin-binding motif (FIGQY1229H) display abnormal 
mapping of RGC axons along the mediolateral axis of the SC, resembling mouse mutant 
phenotypes in EphB receptor tyrosine kinases. To investigate whether L1 functionally interacts 
with EphBs, we investigated the role of EphB kinases in phosphorylating L1 using a phospho-
specific antibody to the tyrosine phosphorylated FIGQY1229 motif. EphB2, but not an EphB2 
kinase dead mutant, induced tyrosine phosphorylation of L1 at FIGQY1229 and perturbed ankyrin 
recruitment to the membrane in L1-transfected HEK293 cells. Src family kinases mediated L1 
phosphorylation at FIGQY1229 by EphB2. Other EphB receptors that regulate medial-lateral 
retinocollicular mapping, EphB1 and EphB3, also mediated phosphorylation of L1 at FIGQY1229. 
Tyrosine1176 in the cytoplasmic domain of L1, which regulates AP2/clathrin-mediated endocytosis 
and axonal trafficking, was not phosphorylated by EphB2. Accordingly mutation of Tyr1176 to Ala 
in L1-Y1176A knock-in mice resulted in normal retinocollicular mapping of ventral RGC axons. 
Immunostaining of the mouse SC during retinotopic mapping showed that L1 colocalized with 
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phospho-FIGQY in RGC axons in retinorecipient layers. Immunoblotting of SC lysates confirmed 
that L1 was phosphorylated at FIGQY1229 in wild type but not L1-FIGQY1229H (L1Y1229H) 
mutant SC, and that L1 phosphorylation was decreased in the EphB2/B3 mutant SC. Inhibition of 
ankyrin binding in L1Y1229H mutant RGCs resulted in increased neurite outgrowth compared to 
WT RGCs in retinal explant cultures, suggesting that L1-ankyrin binding serves to constrain RGC 
axon growth. These findings are consistent with a model in which EphB kinases phosphorylate L1 
at FIGQY1229 in retinal axons to modulate L1-ankyrin binding important for mediolateral 
retinocollicular topography.
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Introduction
The projection of retinal ganglion cell (RGC) axons to the superior colliculus (SC) is a well-
established system for studying highly ordered topographic mapping in the central nervous 
system. In this projection, axons from the temporal-nasal axis of the retina project to the SC 
along its anterior-posterior axis mediated by interaction of complementary gradients of 
repellent ephrinA ligands in the SC and EphA receptor tyrosine kinases in the retina 
(Feldheim et al., 2000; Frisen et al., 1998; Hansen et al., 2004; Lemke and Reber, 2005; 
Yates et al., 2001). Conversely, RGC axons from the dorsal-ventral axis of the retina project 
to the lateral-medial axis in SC mediated by counter gradients of ephrinB1 in the SC and 
EphB receptors (B1, B2, B3) in the retina (Hindges et al., 2002; Lemke and Reber, 2005; 
McLaughlin et al., 2003; Thakar et al., 2011).
The L1 neural cell adhesion molecule contributes to mediolateral retinocollicular 
topography through its ability to engage the actin cytoskeletal adaptor ankyrin (Buhusi et al., 
2008; Demyanenko and Maness, 2003). L1 is an immunoglobulin (Ig)-class transmembrane 
glycoprotein that consists of an extracellular region of 6 Ig-like and 5 fibronectin type III 
repeats, a single-pass transmembrane region, and a short cytoplasmic domain (Moos et al., 
1988). L1 is expressed on developing axons and growth cones in discrete regions of the 
nervous system, where it regulates axon fasciculation and guidance (Maness and Schachner, 
2007). A motif in the cytoplasmic domain of L1 FIGQY1229 binds ankyrin reversibly (Fig. 
1A), thus regulating L1 linkage to the actin cytoskeleton through ankyrin-spectrin bindings 
(Davis and Bennett, 1994; Yap et al., 2008). L1-ankyrin binding is associated with stable 
adhesive contacts and inhibition of retrograde actin flow (Gil et al., 2003; Nishimura et al., 
2003; Whittard et al., 2006), whereas tyrosine phosphorylation of FIGQY abolishes ankyrin 
binding and decreases adhesion (Garver et al., 1997; Jenkins et al., 2001). The serine/
threonine kinase ERK/MAP kinase has been shown to lie upstream of FIGQY 
phosphorylation (Whittard et al., 2006). Another key tyrosine-containing motif Y1176RSL 
that can be phosphorylated in the L1 cytoplasmic domain binds the AP2 clathrin adaptor and 
ezrin-radixin-moesin (ERM) proteins, which engage the actin cytoskeleton (Fig. 1A). This 
motif regulates endocytosis and trafficking of L1 during neurite outgrowth (Cheng et al., 
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2005; Kamiguchi and Lemmon, 1998; Kamiguchi et al., 1998; Wisco et al., 2003), however, 
a role in retinocollicular mapping has not been addressed.
Mutation of tyrosine1229 in the FIGQY motif of L1 to histidine (L1Y1229H) in mice blocks 
ankyrin binding and disrupts retinocollicular mapping specifically along the mediolateral 
axis of the SC (Buhusi et al., 2008). In L1Y1229H mutant mice, axons from the ventral 
retina, which express higher levels of EphB receptors than those from dorsal retina, 
mistarget to inappropriately lateral sites in the SC, where they form multiple ectopic 
arborizations (Buhusi et al., 2008). Mediolateral mistargeting in L1Y1229H mutants is 
phenocopied in EphB1, EphB2, EphB3 single and variant double knockout mice, as well as 
in EphB1- or EphB2 kinase-inactive mutant mice (Hindges et al., 2002; Thakar et al., 2011). 
This evidence raised the possibility that ephrinB/EphB signaling might regulate L1 
phosphorylation and ankyrin binding important for mediolateral retinocollicular axon 
mapping in the SC.
Here we show that EphB receptors induce tyrosine phosphorylation of L1 at FIGQY1229 to 
modulate ankyrin binding. Inhibition of ankyrin binding in L1Y1229H mutant RGCs 
increased RGC neurite outgrowth in ventral retina explants, suggesting that L1-ankyrin 
binding serves to constrain RGC axon growth. In contrast, mutation of tyrosine in the L1-
Y1176RSL motif to alanine did not alter retinocollicular mapping, and EphB did not 
phosphorylate the Y1176RSL. These findings are consistent with a model in which EphB 
kinases regulate ankyrin binding to L1 through tyrosine phosphorylation at the L1 FIGQY 
motif, in this way modulating RGC axon growth for appropriate targeting of retinal axons 
along the mediolateral axis of the SC.
Results
EphB receptor mediates tyrosine phosphorylation of L1 in the ankyrin binding motif 
FIGQY
EphB2 is the most prominent EphB receptor exhibiting graded expression in the mouse 
retina along the dorsal-ventral axis during retinocollicular mapping from postnatal day 0 
to10 (P0-P10), where it cooperates with EphB1 and EphB3 to regulate responses of RGC 
axons to the mediolateral SC gradient of ephrinB1 (Hindges et al., 2002; Thakar et al., 
2011). To investigate whether EphB2 kinase was capable of phosphorylating L1 on Y1229 in 
the FIGQY ankyrin binding motif, L1 and EphB2 were co-expressed in HEK293 cells, and 
phosphorylation of L1 at Y1229 was analyzed by immunoblotting with a phospho-specific 
antibody recognizing the tyrosine phosphorylated FIGQY sequence (p-FIGQY). This 
antibody was raised against a peptide encompassing the FIGQY sequence of L1, similar to a 
previously described phospho-FIGQY antibody raised against the homologous sequence in 
Neurofascin (Jenkins et al., 2001; Kizhatil et al., 2002). In cells expressing L1 and EphB2, 
phosphorylation of L1 at FIGQY was strongly increased compared to L1 in cells not 
expressing EphB2 (Fig. 1B). Both differentially glycosylated forms of mature L1 protein 
(200, 220kDa) (He et al., 2009) were recognized by p-FIGQY antibody and showed 
increased phosphorylation by EphB2. A low level of p-FIGQY was seen in cells transfected 
with L1 alone, which was likely due to endogenous tyrosine kinases. Treatment of cells with 
the EphB ligand ephrinB1 did not increase p-FIGQY levels in cells expressing L1 with or 
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without EphB2 (Fig. 1B), probably due to autoactivation typically resulting from 
overexpressed receptor kinases. The specificity of the p-FIGQY antibody for L1 
phosphorylated on Y1229 was demonstrated by immunoblotting of L1 immunoprecipitated 
from HEK293 cells expressing the L1Y1229H mutant (L1YH). No p-FIGQY signal was 
evident in L1Y1229H from cells with or without EphB2 co-expression (Fig. 1C).
To investigate the specificity of EphB receptors in phosphorylating L1, EphB1and EphB3 
were similarly evaluated, as they are also involved in mediolateral retinocollicular targeting 
(Hindges et al., 2002; Thakar et al., 2011). EphB2, EphB1 and EphB3 of mouse origin were 
all capable of phosphorylating L1 at FIGQY, however EphB2 of chick origin (cEphB2) 
always elicited higher phosphorylation of L1 (Fig. 1D). To evaluate the ability of EphBs to 
co-immunoprecipitate with L1, blots were reprobed with antibodies recognizing cEphB2 and 
mEphB2 or anti-HA antibody recognizing HA-tagged mEphB1 and mEphB3. Results 
showed that each of the EphBs coimmunoprecipitated with L1, thus indicating a direct or 
indirect molecular association (Fig. 1D). To determine if the kinase activity of EphB2 was 
essential for the phosphorylation of FIGQY, a chicken kinase-dead EphB2 mutant 
(EphB2K662R; EphB2 KD) (Zisch et al., 1998) was cotransfected with L1 into HEK293 
cells, then L1 was analyzed in immunoprecipitates by immunoblotting with p-FIGQY 
antibody. Unlike WT EphB2, EphB2 KD did not support L1 phosphorylation at the FIGQY 
motif (Fig. 1E).
The non-receptor tyrosine kinase, pp60c-src, is recruited to activated EphB receptors 
including EphB2 by binding with two conserved phosphorylated tyrosine in the 
juxtamembrane of EphB2 (Vindis et al., 2003; Zisch et al., 1998; Zisch et al., 2000). To 
assess whether Src family members might be involved in tyrosine phosphorylation of L1 at 
FIGQY by EphBs, the Src family kinase inhibitor PP2 was added to HEK293 cells 
expressing L1 and EphB2. Phosphorylation of L1 at FIGQY by EphB2 was completely 
inhibited by PP2 (Fig. 1E). In contrast, the nonfunctional analog PP3 did not decrease the p-
FIGQY level on L1 (Fig. 1E). Therefore, pp60c-src or another Src-related family kinase, such 
as pp59c-fyn or pp62c-yes, may function as a downstream effector of EphB2 kinase in 
phosphorylating L1 at FIGQY.
Tyrosine1176 in the YRSL motif of L1 is neither phosphorylated by EphB nor involved in 
retinocollicular mapping
L1 engages the clathrin adapter AP2 and ERM proteins at Tyr1176 located within the YRSL 
motif of the L1 cytoplasmic domain. This sequence can be phosphorylated by pp60c-src on 
Tyr1176 (Schaefer et al., 2002), and is important for AP2/clathrin-mediated endocytosis and 
axonal trafficking (Kamiguchi and Lemmon, 1998; Kamiguchi et al., 1998; Wisco et al., 
2003) during growth cone navigation (Itofusa and Kamiguchi, 2011). ERMs mediate L1-
induced axon branching (Cheng et al., 2005) and guidance (Mintz et al., 2008), as well as 
Semaphorin3A-induced growth cone collapse (Mintz et al., 2008; Schlatter et al., 2008). To 
examine whether EphB2 was able to phosphorylate L1 on tyrosine in the Y1176RSL motif, 
we took advantage of a phosphorylation-state specific antibody (74-5H7) that recognizes 
only the non-phosphorylated Y1176RSL sequence (Schaefer et al., 2002). L1 was 
immunoprecipitated from lysates of HEK293 cells expressing L1 alone or L1 and EphB2, 
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and the levels of non-phosphorylated L1-Y1176RSL were compared by immunoblotting with 
74-5H7 antibody. No differences were observed in the relative levels of non-phosphorylated 
L1 at Y1176RSL detected by this antibody in L1-expressing HEK293 cells with or without 
EphB2 (Fig. 1F). These results indicated that overexpressed EphB2 was unable to induce 
tyrosine phosphorylation of L1 at Y1176RSL in HEK293 cells.
Mutation of L1 Tyr1176 to alanine inhibits AP2 and ERM binding (Cheng et al., 2005; 
Dickson et al., 2002). Knock-in mice with this point mutation (L1Y1176A) display normal 
brain morphology (Nakamura et al., 2010) but they have not been examined for 
consequences on retinocollicular mapping. To investigate whether mediolateral mapping of 
RGC axons from the ventral retina to the SC was perturbed by mutation of L1 Tyr1176 to 
alanine, we performed axon tracing in homozygous L1Y1176A and L1Y1229H mutant mice, 
as well as WT controls by injecting DiI into the ventro-temporal retina at P10-12, and 
comparing the location of termination zones (TZs) in the SC after 48 hour. Ventro-temporal 
axons express high levels of EphB receptors and normally project to the anteromedial SC, 
thus their attraction to the medial-high ephrinB1 gradient in the SC makes them very 
sensitive to alterations in mediolateral targeting controlled by ephrinB1/EphB signaling 
(Hindges et al., 2002; Thakar et al., 2011). DiI injection into the ventro-temporal retina 
labeled a single TZ in the anteromedial SC of WT mice and multiple, laterally-displaced 
ectopic TZs in the SC of L1Y1229H mice (Fig. 2), as shown previously (Buhusi et al., 2008). 
DiI injections into the ventro-temporal retina of L1Y1176A mutant mice resulted in normally 
positioned TZs in the anteromedial SC in all cases (7/7 mice) (Fig. 2). In all L1Y1176A null 
mutants, a single, dense TZ was located in an appropriate location along both the 
mediolateral and anteroposterior axes of the SC. Thus, interactions mediated by the YRSL 
motif in the L1 cytoplasmic domain did not appear to be critical determinants of 
retinocollicular mapping in the mediolateral axis, underscoring the importance of the 
ankyrin binding domain of L1 in EphB-mediated retinal axon guidance.
EphB2 inhibits recruitment of ankyrin to the membrane of L1-expressing cells by 
phosphorylation of the ankyrin binding motif FIGQY
Tyrosine phosphorylation of the highly conserved FIGQY domain of L1 family members 
abolishes ankyrin binding (Garver et al., 1997). The missense mutation Y1229H of L1 
FIGQY domain abolishes ankyrin recruitment to L1 in vivo and in a cellular recruitment 
assay to the membrane in L1-expressing HEK293 cells (Buhusi et al., 2008; Needham et al., 
2001). To evaluate the ability of EphB2 to modulate L1-ankyrin binding, we used the 
cytofluorescence assay as described by Needham et al (2001) which measures L1-dependent 
recruitment of EGFP-labeled ankyrinG from the cytoplasm to the plasma membrane in 
transfected HEK293 cells (Needham et al., 2001). Expression of EGFP-ankyrinG alone 
resulted in diffuse EGFP fluorescence in the cytoplasm, whereas co-expression of L1 and 
EGFP-ankyrinG resulted in recruitment of fluorescence to the plasma membrane where L1 
was localized (Fig. 3A), in accord with previous results (Needham et al., 2001). When 
EphB2 was co-expressed with L1 under conditions shown to result in tyrosine 
phosphorylation at FIGQY, EGFP-ankyrinG remained distributed throughout the cytoplasm 
(Fig. 3A). The observation that a percentage of cells expressing L1 and EphB2 displayed 
residual ankyrinG recruitment to the membrane suggested that L1 may be incompletely 
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phosphorylated. In contrast, co-expression of the EphB2 KD mutant with L1 led to the 
recruitment of ankyrinG to the membrane (Fig. 3A).
Quantification of these results showed that greater than 70% of cells co-expressing L1 and 
EGFP-ankyrinG displayed recruitment of ankyrinG to the membrane, which was 
significantly greater than the percent of cells expressing EGFP-ankyrinG alone (18%) (Fig. 
3B). In cells co-expressing L1 and EphB2 the percent of cells exhibiting ankyrinG 
recruitment to the membrane significantly decreased, and further decreased with ephrinB1-
Fc treatment (Fig. 3B). In cells co-expressing L1 and EphB2 KD the percent of cells 
exhibiting ankyrinG recruitment was equal to that of L1 alone (Fig. 3B). Co-expression of 
L1Y1229H and EGFP-ankyrinG with or without EphB2, or with EphB2 under ephrinB1 
treatment did not induce recruitment of ankyrin to the plasma membrane at a level similar to 
that of cells expressing EGFP-ankyrinG alone (Fig. 3B). The phosphorylation of L1 by 
EphB2 was confirmed by positive p-FIGQY immunoblotting of L1 immunoprecipitated 
from lysates of EGFP-ankyrinG-expressing HEK293 cells transfected with L1/EphB2 but 
not with L1/EphB2 KD or L1Y1229H (with or without EphB2) (Fig. 3C). These results were 
consistent with the interpretation that phosphorylation of L1 at the FIGQY motif by EphB2 
kinase reduces L1-ankyrin interaction in a cellular context.
The FIGQY domain of L1 is phosphorylated in retinal ganglion cell axons in the superior 
colliculus
Retinocollicular targeting in mouse begins from embryonic day 14 (E14), when RGC axons 
first reach the SC, to postnatal day 10 (P10), when topographic mapping is largely 
completed (Simon and O’Leary, 1992). The map is further refined in an activity-dependent 
manner after eye opening around P12 (Schmidt, 2004). Studies in vitro and in vivo have 
demonstrated a pivotal role for the ankyrin binding motif of L1 (FIGQY) in retinocollicular 
mapping (Buhusi et al., 2008; Hortsch et al., 2009). To determine whether L1 was 
phosphorylated at FIGQY on retinal axons during retinocollicular mapping in vivo, we 
evaluated the co-localization of L1 and p-FIGQY immunoreactivity within the early 
postnatal SC of the mouse during retinal axon navigation (P7) by double 
immunofluorescence staining. L1 and p-FIGQY immunoreactivity were observed in fibers 
within the superficial layers of the SC (stratum griseum superficiale (SGS) and stratum 
opticum (SO)), where incoming RGC axons are localized at this stage (Fig. 4A). A portion 
of the p-FIGQY immunofluorescence was punctate and co-localized with L1 in fibers within 
the superficial layers, as indicated in merged images (Fig. 4A). Additional p-FIGQY 
immunofluorescence did not co-localize with L1 but was evident in some fibers within the 
retinorecipient layers, as well as in a non-fibrous pattern in other laminae of the SC. Control 
staining with nonimmune IgG was minimal.
When L1 was immunoprecipitated from WT SC lysates at P3 and immunoblotted with p-
FIGQY antibody, labeled proteins corresponded to intact L1 (220 kDa) and its most 
abundant carboxyl terminal cleavage fragment (80 kDa), which is generated in mouse brain 
by a proprotein convertase (Kalus et al., 2003) (Fig. 4B, upper panel). Reprobing with a 
monoclonal antibody against the L1 carboxyl terminus confirmed the identity of these 
protein bands as L1 (Fig. 4B, upper panel). L1 phosphorylated at FIGQY in SC lysates was 
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also recognized by a general phosphotyrosine-specific antibody (Fig. 4B, lower panel). 
Other L1 family members CHL1, Neurofascin (NF), and NrCAM were also expressed in the 
P3 SC as shown by immunoprecipitation and immunoblotting with respective antibodies 
from SC lysates (Fig. 4B, lower panel). Due to the close homology between L1 and NrCAM 
within the FIGQY-containing sequence, the p-FIGQY antibody recognized a very small 
amount of NrCAM immunoprecipitated from the SC lysates, but no p-FIGQY signal was 
detected in CHL1 or Neurofascin at equivalent exposures to that used for L1 (Fig. 4B, lower 
panel). Thus, p-FIGQY staining in fibers not co-localizing with L1, might represent low 
levels of NrCAM expressed on RGC axons. As a further negative control, the p-FIGQY 
antibody clearly did not recognize L1 lacking Tyr1229 immunoprecipitated from L1Y1229H 
mutant SC at P3 (Fig. 4C). These results were consistent with tyrosine phosphorylation of 
L1 at FIGQY1229 in RGC axons within the SC during early stages of postnatal targeting.
To investigate whether the expression of EphB receptors is correlated with phosphorylation 
of L1 at FIGQY in the SC, L1 was immunoprecipitated from SC lysates of WT and 
EphB2/B3 double knockout (DKO) mice at P5, and immunoblotted with p-FIGQY antibody. 
The 220 kDa L1 band recognized by p-FIGQY antibody in WT SC was decreased in the 
EphB2/B3 DKO SC, despite equivalent amounts of L1 in immunoprecipitates (Fig. 4D). 
Quantification of results from multiple mice showed that the ratio of p-FIGQY to L1 in the 
220 kDa band of EphB2/B3 DKO SC (40 ± 2 %, Means± S.E.M., n=6) was significantly 
lower (~30%) than that in WT SC (58 ±1 %, Means± S.E.M., n=3) (t-test, p<0.001). The 
residual p-FIGQY present in L1 may be due to phosphorylation by EphB1 or another 
tyrosine kinase, or may derive from p-FIGQY positive cells that were not located in the 
superficial retinorecipient layers of the SC.
Effect of FIGQY mutation on regulation of retinal axon outgrowth in explant cultures
Dorsal-ventral differences in RGC axon responses to ephrinB gradients are difficult to 
observe in culture as previously discussed (Hindges et al., 2002). Therefore, the 
consequences of FIGQY mutation on RGC neurite outgrowth were analyzed in a model 
system in which retinal explants from WT and L1Y1229H mutant mice (P3) were cultured on 
fibronectin/poly-lysine. It was previously shown that L1-ankyrin binding enhances integrin-
dependent adhesion of retinal cells to fibronectin (Buhusi et al., 2008), a substrate present on 
radial glia in the SC/optic tectum (Stettler and Galileo, 2004). Neurite growth in this assay is 
also promoted by shed L1 extracellular fragments adhering to the substrate (Mechtersheimer 
et al., 2001). After 3 days in vitro, WT retinal explants displayed evident outgrowth of RGC 
neurites, as visualized by immunofluorescence staining with TuJ1 antibody to β III tubulin 
(Fig. 5B). There was no difference in neurite growth from retinal explants isolated from the 
dorsal or ventral quarters of the WT retina (Fig. 5A), in accord with results from Hansen et 
al., (Hansen et al., 2004) who showed no differences in neurite growth of explants derived 
from different axial positions in the mouse retina. Neurite outgrowth of RGCs from 
L1Y1229H ventral explants was substantially greater than that of WT (Fig. 5A,B). Some 
neurites from L1Y1229H mutants extended far from the explants, in addition to some with 
comparable length to WT (Fig. 5B). Axon outgrowth was quantified in multiple explant 
cultures by measuring length of TuJ1-positive neurites extending from the edge of the 
explant to the periphery. Outgrowth of RGC axons from retinal explants of L1Y1229H 
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mutant mice was significantly greater than that of WT (Fig. 5A; t-test, p<0.05). 
Immunofluorescence staining of the explant cultures with p-FIGQY antibody showed that 
WT retinal neurites displayed L1 phosphorylation, not observed in L1Y1229H neurites (Fig. 
5C). WT L1 phosphorylation was likely due to endogenous receptor tyrosine kinases 
activated by growth factors in the medium. Increased neurite growth of L1Y1229H RGCs 
may be due to decreased adhesion, as integrin-dependent adhesion to fibronectin was 
decreased in L1Y1229H mutant RGCs (Buhusi et al., 2008).
Furthermore, studies of sensory and cerebellar neurons treated with peptide inhibitors of L1-
ankyrin binding, or ankyrinB null mice suggest that L1-ankyrin binding fosters stationary 
behavior by inhibiting retrograde actin flow (Gil et al., 2003; Nishimura et al., 2003). 
Whether such a mechanism extends to axon branch attraction in the SC induced by ephrinB/
EphB is not clear. Our results with RGCs from L1Y1229H mutant mice support an 
interpretation that phosphorylation of L1 at the FIGQY motif promotes neurite outgrowth of 
RGCs, potentially by reducing stationary behavior and adhesion.
Discussion
Here we show that EphB receptor tyrosine kinases interact with L1 by regulating tyrosine 
phosphorylation at the ankyrin binding motif FIGQY in the L1 cytoplasmic domain and that 
this modification modulates ankyrin binding, a key molecular interaction important for 
mediolateral retinocollicular axon targeting. EphB2 kinase induced phosphorylation of L1 at 
the FIGQY motif and inhibited ankyrin recruitment to cell membrane expressing L1 in 
HEK293 cells in vitro. EphB1 and EphB3, in addition to EphB2 were capable of associating 
with L1 and phosphorylating L1 at the FIGQY motif. Moreover, Tyr1229 within the FIGQY 
motif of L1 was phosphorylated in retinal axons in the SC of early postnatal WT mice 
during retinocollicular axon mapping, and this phosphorylation decreased in the SC of mice 
deficient in EphB2 and EphB3, and was completely lost in L1Y1229H mutant SC. In contrast 
Tyr1176 in the L1 YRSL motif, which is a critical determinant of AP2/clathrin and ERM 
binding, was not phosphorylated by EphB2, and mutation of this motif in L1 Y1176RSL 
mutant mice did not impair retinocollicular mapping. These findings implicate EphB 
receptor signaling in regulating L1 phosphorylation at Tyr1229 as a critical modulator of 
ankyrin interactions occurring during retinocollicular axon targeting.
EphB1, EphB2, and EphB3 were able to phosphorylate L1 at FIGQY and to associate with 
L1 in vitro, thus each receptor has the potential to regulate L1-ankyrin interactions during 
retinocollicular axon targeting. EphB1, EphB2, and EphB3 null mutant mice, as well as 
EphB1- and EphB2 kinase-inactive mutants, exhibit mediolateral SC mistargeting of ventral 
retinal axons, similar to the phenotype of L1Y1229H mutant mice (Buhusi et al., 2008; 
Hindges et al., 2002; Thakar et al., 2011). Enhancement of the mistargeting phenotype by 
double deletion of EphB2 and EphB3, and other specific EphB combinations, implicates 
multiple EphBs in mediolateral mapping (Thakar et al., 2011). Based on inhibition of 
EphB2-induced phosphorylation of L1 in the presence of a selective Src inhibitor PP2, Src 
family kinases downstream of EphBs may mediate phosphorylation of L1 at the FIGQY 
motif. Among the Src family kinases expressed in neurons (pp60c-src, p59fyn, p62c-yes), 
pp60c-src is a good candidate as it is known to be recruited to activated EphB receptors 
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(Vindis et al., 2003; Zisch et al., 1998) and it regulates neurite outgrowth of cerebellar 
neurons on L1 (Ignelzi et al., 1994). However, pp60c-src does not promote phosphorylation 
of L1 at FIGQY in all cells and pathways (Schaefer et al., 2002; Whittard et al., 2006). Our 
findings are in agreement with an earlier report showing that co-transfection of L1 and the 
chicken EphB2 homologue Cek5 into a glioblastoma cell line induces L1 tyrosine 
phosphorylation, although the tyrosine residue was not identified (Zisch et al., 1997).
Overall, the results are consistent with the interaction between L1 and EphB receptors that 
activates forward EphB2 signaling through pp60c-src to induce FIGQY phosphorylation. It is 
not excluded that EphB and L1 also function in the SC to modulate RGC axon navigation 
through reverse signaling, as shown in retinal cell cultures (Suh et al., 2004). Regulation of 
ankyrin binding by EphB-mediated tyrosine phosphorylation of L1 at FIGQY may promote 
axon growth and branch orientation of ventral RGCs toward the medial-high ephrinB1 in the 
SC. In support of this, outgrowth of ventral RGC axons from L1Y1229H mutant mice was 
greater than that of WT in explant cultures. An analogous role for L1-ankyrin binding in 
constraining neurite outgrowth has been described for cerebellar and hippocampal neurons 
(Boiko et al., 2007; Gil et al., 2003; Whittard et al., 2006).
In contrast to the FIGQY ankyrin binding motif, the YRSL sequence in the L1 cytoplasmic 
domain did not play a significant role in retinocollicular mapping. Mutation of Tyr1176 to 
Ala in the YRSL motif did not alter mediolateral or anteroposterior mapping of retinal axons 
in the mouse SC. Although L1 Tyr1176 can be phosphorylated by pp60c-src in vitro and in 
vivo (Schaefer et al., 2002), it did not induce L1 phosphorylation at this site in EphB2-
expressing HEK293 cells. Because this sequence is involved in regulating AP2/clathrin-
mediated endocytosis, ERM interactions, and axon trafficking (Cheng et al., 2005; 
Kamiguchi and Lemmon, 1998; Kamiguchi et al., 1998; Wisco et al., 2003), these functions 
may not play a major role in topographic targeting of ventro-temporal axons.
Our findings suggest a model in which ephrinB1/EphB induces tyrosine phosphorylation of 
L1 at FIGQY1229 through EphB and Src kinase activity, decreasing ankyrin binding and 
promoting RGC axon growth and/or branch attraction to terminations zones along the 
mediolateral gradient of ephrinB1 (Fig. 6).
Dephosphorylation of L1-FIGQY through tyrosine phosphatases would conversely increase 
ankyrin binding and spectrin-mediated linkage to the actin cytoskeleton, potentially 
stabilizing synaptic terminals. In an analogous manner, ankyrin binding to non-
phosphorylated FIGQY in L1 family proteins is associated with cessation of axon growth 
and formation of synapses (Ango et al., 2004; Boiko et al., 2007; Gil et al., 2003; 
Godenschwege et al., 2006; Hortsch et al., 2009; Nishimura et al., 2003; Tuvia et al., 1997). 
The mutation L1Y1229H inhibits ankyrin binding and thus could decrease adhesion/
stabilization of RGC axons at termination zones in retinocollicular axon targeting. The 
residual p-FIGQY of L1 in EphB2/B3 double null mutant mice suggests that other signaling 
pathways participate in phosphorylation of the FIGQY ankyrin binding motif. For example, 
nerve growth factor (NGF), fibroblast growth factor (FGF), and epidermal growth factor 
(EGF) promote phosphorylation of L1 proteins at highly conserved FIGQY domains (Garver 
et al., 1997; Gil et al., 2003; Tuvia et al., 1997; Whittard et al., 2006). Among these, FGF 
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signaling has a demonstrated role in retinotectal mapping in Xenopus (McFarlane et al., 
1996) and influences EphB2 phosphorylation (Poliakov et al., 2008). In addition brain-
derived neurotrophic factor (BDNF) signaling through TrkB serves as a branch promoting 
factor for retinal axons (Feldheim and O’Leary, 2010; Poopalasundaram et al., 2011). Thus, 
growth factor and ephrinB/EphB signaling pathways might converge at the level of cell 
adhesion molecule phosphorylation to coordinately regulate ankyrin binding and modulate 
retinal axon growth and branch migration within the SC.
In summary, our findings demonstrate that EphB receptors function in regulating 
phosphorylation of the L1 ankyrin binding motif, and thus provide insight into the functional 
mechanism of cross-talk between ephrin/Eph signaling and cell adhesion molecules 
necessary for accurate retinocollicular topography.
Experimental Methods
Mice
L1Y1229H (Buhusi et al., 2008) and L1Y1176A mutant mice (Nakamura et al., 2010) were 
previously characterized. Because the L1 gene is on the X chromosome, heterozygous 
females were crossed with C57BL6 WT males to obtain WT and hemizygous male mutants 
for analyses. Homozygous EphB2/EphB3 double null mutants (Hindges et al., 2002) were 
generated using protein null mouse mutants in EphB2 (Henkemeyer et al., 1996) and EphB3 
(Orioli et al., 1996). Mice were used according to the Institutional Animal Care and Use 
Committee policies of the University of North Carolina at Chapel Hill and the University of 
Texas Southwestern Medical Center in accordance with National Institutes of Health 
guidelines.
Production of p-FIGQY antibody
The generation and characterization of p-FIGQY antibody was similar to those raised to the 
homologous phosphorylated peptide in rat Neurofascin (Jenkins et al., 2001). Affinity 
purified p-FIGQY antibody were raised in rabbits against a tyrosine phosphorylated peptide 
surrounding the FIGQY1229 ankyrin binding sequence (NEDGSFIGQ(pY)SGKKE) in 
mouse L1 and purified by Bethyl Laboratories, Inc. (Montgomery, TX) as described briefly 
below. The immunogen peptide CNEDGSFIGQ(pY)SGKKE was synthesized with an added 
cysteine residue at the N-terminus and coupled to the immunogenic carrier protein keyhole 
limpet hemocyanin. Rabbits were immunized with the phospho-peptide and antibody was 
affinity-purified by processing over the non-phosphorylated FIGQY peptide immobilized to 
an immunosorbent column. The flow through was then purified on another immunosorbent 
column to which was coupled the phosphorylated FIGQY peptide. The antibody was eluted, 
stored in aliquots at −70°C, and characterized for recognition of L1 phosphorylated on 
Tyr1229 versus L1 Y1229H (negative control), and other L1 family members (CHL1, 
Neurofascin, NrCAM) by immunoblotting of transfected HEK293 cells and SC lysates (Fig. 
1C and Fig. 4B,C).
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Cell culture, brain lysates, immunoblotting, and immunoprecipitation
HEK293T cells were cultured in DMEM with 10% bovine fetal serum. Expression plasmids 
encoding human L1, human L1Y1229H, chicken EphB2 and EphB2 kinase dead mutant 
(EphB2K662R; EphB2 KD) (Zisch et al., 1998), mouse EphB1 containing a hemagglutinin 
epitope tag (HA), mouse EphB2 and mouse EphB3 containing HA-tag were transfected into 
HEK293T cells using Lipofectamine 2000 in Opti-MEM medium (Invitrogen) as described 
(Schlatter et al., 2008). After 48 hours, cells were washed with Hank’s Balanced Salt 
Solution and lysates were prepared. In some experiments the Src family kinase inhibitor PP2 
(4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyramidine) (2 μM; Calbiochem, 
Darmstadt, Germany) or its nonfunctional analogue PP3 (4-amino-7-phenylpyrazolo[3,4-
d]pyramidine) (2 μM; Calbiochem, Darmstadt, Germany) were added to cells for 20 minutes 
before lysis. For ephrinB1 treatment, 3 nM mouse ephrinB1-Fc protein (R&D Systems, 
Minneapolis, MN) preclustered with 0.3 nM anti-human Fc (Jackson ImmunoResearch, 
West Grove, PA) for 30 minutes on ice were incubated with HEK293 cells in Opti-MEM for 
15 minutes at 37 °C before lysis. Lysates of mouse superior colliculus (SC) were prepared as 
described (Buhusi et al., 2008). Transfected HEK293T cells or SC tissues were 
homogenized on ice in RIPA buffer containing protease inhibitors and phosphatase 
inhibitors (1% NP-40, 1% sodium deoxcholate, 0.1% sodium dodecyl sulfate, 0.15 M NaCl, 
5 mM Na-EDTA, 1 mM Na-EGTA in 20 mM Tris-HCl, pH 7.0, 10 μg/mL leupeptin, 0.11 
TIU/mL aprotinin, 0.2 mM sodium orthovanadate, and 10 mM sodium fluoride). Lysates 
were clarified by centrifugation at 14000 rpm. Protein concentration was measured by the 
BCA method (Pierce Biotechnology, Rockford, IL). Transfected cell lysates (500 μg) were 
immunoprecipitated with mouse anti-L1 monoclonal (UJ127) antibody (1 μg; Abcam, 
ab3200) or normal mouse IgG for 2 h at 4°C, following incubation with protein A/G-
Sepharose beads (Pierce Biotechnology, Rockford, IL) for 30 min at 4°C. Beads were 
washed with RIPA buffer, and proteins were eluted by boiling in SDS-PAGE sample buffer. 
SC lysates (1000 μg) were precleared with protein A/G-Sepharose beads for 30 min at 4°C. 
For L1 immunoprecipitation, precleared lysates were incubated with mouse anti-L1 
monoclonal antibodies 2C2 (2.5 μg; Abcam, ab24345) and 5G3 (2.5 μg; BD Bioscience, 
554273) for 2 h at 4°C, then incubated with protein A/G-Sepharose beads for another 30 min 
at 4°C. Beads were washed with RIPA and proteins were eluted by boiling in SDS-PAGE 
sample buffer. Similarly, immunoprecipitation of NrCAM, Neurofascin or CHL1 from P3 
SC lysates were done by corresponding antibodies to NrCAM (Abcam, ab24344), 
Neurofascin (obtained from Dr. Peter Brophy) or CHL1 (R&D systems, AF2147). The 
immunoprecipitates were resolved on 7.5% SDS-PAGE gels and transferred to 
nitrocellulose membranes. After blocking in 5% non-fat dry milk or 5% BSA, the 
membranes were immunoblotted with antibodies to p-FIGQY (1:500), L1 (UJ127, 1:1000; 
Abcam, ab3200), L1 (2C2, 1:1000;; Abcam, ab24345), EphB2 (1:2000; Invitrogen, 
36-6100), HA (1:1000; BaBco, HA-11), phosphotyrosine (1:1000; Cell Signaling 
Technology, 9411), NrCAM (0.4 ug/ml; Abcam, ab24344), CHL1 (1:1000; R&D system, 
AF2147), Neurofascin (1:5000) or non-p-Y1176RSL (74-5H7, 1:1000; provided by Dr. 
Vance Lemmon). Bands were developed on X-ray film by enhanced chemiluminescence 
(Perkin-Elmer, Waltham, MA), and quantified by densitometry.
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Retinal explant cultures and neurite length measurements
Retinal explants were prepared from the dorsal or ventral quarter of P3 WT and L1Y1229H 
mice as described previously (Wang et al., 2002). Mat-Tek plates were coated with 33 μg/ml 
poly-D lysine and followed by coating with 3 μg/ml fibronectin. Explants were cultured on 
the Mat-Tek plates in Neurobasal A medium containing 0.7% methyl cellulose, B27 
supplement (Invitrogen) and 10 μg/ml gentimycin (Gibco BRL) for 3 days. Explants were 
fixed with 4% paraformaldehyde for 10 minutes and 0.2% Triton x-100 in PBS for 2 
minutes at room temperature for immunostaining of p-FIGQY (1:250), or the neuronal 
marker β III tubulin using TuJ1 antibody (1:500; Covance). To quantify neurite outgrowth 
from retinal explants, the length (μm) of 40 randomly selected neurites from each explant 
was measured and averaged using NIH Image J software. Mean neurite length of explant 
was calculated for multiple samples, and compared between genotypes by Student’s t-test 
for significant differences (P < 0.05).
Immunofluorescence staining
WT and L1Y1229H mutant mice at postnatal day 7 (P7) were anesthetized with isoflurance 
and perfused transcardially with 4% paraformaldehyde (PFA) in 0.01 M phosphate-buffered 
saline (PBS). The brains were post-fixed in 4% PFA overnight at 4°C and sectioned in the 
sagittal plane (16 μm) in a cryostat after cryoprotection with 30% sucrose in PBS. Sections 
were blocked in 2% BSA/10% normal donkey serum/0.2% Triton x-100 in PBS at 4°C 
overnight. Then sections were incubated with rat anti-L1 monoclonal antibody (1:200; 
Millipore, MAB5272) and rabbit anti-p-FIGQY (1:50) antibody at room temperature for 2 
hours. Signals were developed by incubating sections with FITC-conjugated donkey anti-rat 
IgG (1:200; Jackson Immunoresearch) and TRITC-conjugated donkey anti-rabbit IgG 
(1:200; Jackson Immunoresearch) for 1 hour at room temperature. Images were obtained by 
Zeiss 710 confocal microscopy.
L1-ankyrin recruitment assay
Ankyrin recruitment to the plasma membrane of L1-transfected HEK293 cells was assayed 
as previously described (Needham et al., 2001). Briefly, HEK293T cells on poly-D-lysine 
coated Mat-Tek dishes were transfected with plasmid pEGFP-N1 expressing ankyrinG-
EGFP fusion protein, pcDNA3 plasmid expressing WT human L1 or pcDNA3 plasmid 
expressing mutant human L11229H, and/or pcDNA3 plasmid expressing chicken EphB2 or 
EphB2 kinase dead mutant (Zisch et al., 1998) using Lipofectamine 2000. After 18 hr, some 
cultures were treated with mouse ephrinB1-Fc chimeric protein (R&D Systems, 
Minneapolis, MN; 2 μg/ml) or normal mouse IgG control (2 μg/ml) for 15 min. All cultures 
were fixed in 4% paraformaldehyde/PBS and blocked in 10% normal goat serum. Cultures 
were subjected to immunofluorescence staining with antibodies against extracellular region 
of L1 (mAb UJ127) or EphB2 (Zisch et al., 1998) using Cy3 donkey anti-mouse and Cy5 
donkey anti-rabbit secondary antibodies, respectively. Confocal images were captured using 
the 488 nm excitation line of the laser for ankyrin-EGFP. Cells were scored in 3 or 4 
replicate cultures for the percent of single-labeled (ankyrinG-EGFP), double-labeled (L1 or 
L1Y1229H, ankyrinG-EGFP) or triple-labeled (L1 or L1Y1229H, EphB2 or EphB2 KD, 
ankyrinG-EGFP) cells that display ankyrinG-EGFP recruited to the cell surface using 
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criteria described in (Buhusi et al., 2003; Needham et al., 2001). Means ± S.E.M. were 
compared for statistically significant differences using one-way ANOVA and Tukey’s post-
hoc comparisons (p< 0.001).
Retinocollicular Axon Tracing
Axonal tracing was performed as described previously (Demyanenko and Maness, 2003). 
L1Y1176A mutant and WT littermates at P10-P12 were anesthetized and anterograde tracing 
was performed by focal injection of DiI (Invitrogen, Carlsbad, CA) as a 10% solution in 
dimethylformamide into the peripheral region of the ventrotemporal retina using a 
picospritzer and glass micropipettes. After 48h, mice were anesthetized and perfused 
transcardially with 4% paraformaldehyde in 0.1M phosphate buffer (pH 7.4). Before 
removing the retina, the eye was visually inspected to identify the injection site and assess 
its position in the required quadrant relative to the extraocular muscles (lateral and inferior 
recti). The eyes were removed and incisions were made to demarcate the quadrants of the 
retina. Injected retinas, superior and inferior colliculi were whole-mounted and examined by 
epifluorescence microscopy. The injection sites covered 3-5% of the retina. Termination 
zones (TZs) of labeled retinal axons in the superior colliculus were identified by their 
densely branched appearance under high magnification.
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Figure 1. EphB2 receptor mediates tyrosine phosphorylation of L1 at FIGQY motif
A. Location of tyrosine-containing motifs in the L1 cytoplasmic domain that bind ezrin-
radixin-moesin (ERM) proteins, the clathrin adaptor AP2, and ankyrin. B-E. 
Immunoblotting (IB) with p-FIGQY antibody in L1 immunoprecipitates (IP) from 
transfected HEK293 cells or control precipitates with nonimmune IgG (NIgG). Ratios of 
phosphorylated L1 to L1 protein (pL1/L1) were obtained by densitometry after reprobing 
with L1 antibody.
(B) Expression of L1 and EphB2 increased L1 phosphorylation at FIGQY in transfected 
HEK293 cells compared to cells expressing only L1. Addition of ephrinB1 to cells did not 
further increase p-FIGQY in L1.
(C) p-FIGQY antibody did not recognize L1 immunoprecipitated from HEK293 cells 
transfected with L1Y1229H (L1YH) with or without EphB2 co-expression.
(D) Mouse mEphB2, mEphB1 (HA-tagged) and mEphB3 (HA-tagged) induced 
phosphorylation of L1 at FIGQY when expressed in HEK293 cells, while chick cEphB2 was 
the most effective (top panel). mEphB2, cEphB2, mEphB1-HA, and mEphB3-HA each co-
immunoprecipitated with L1 as shown by immmunoblotting of L1 immunoprecipitates with 
EphB2 antibodies or anti-HA antibody (lowest panel).
(E) EphB2 kinase activity was required for phosphorylation of FIGQY, as EphB2 kinase 
dead mutant (EphB2 KD) did not induce p-FIGQY in L1-expressing HEK293 cells. The Src 
kinase inhibitor PP2 decreased phosphorylation of L1 in L1/EphB2 co-transfected HEK293 
cells, while the nonfunctional analog PP3 had no effect.
(F) EphB2 did not induce tyrosine phosphorylation of L1 at Y1176RSL in HEK293 cells, as 
indicated by equal levels of non-phosphorylated Y1176RSL in L1 detected by 74-5H7 
antibody, which specifically recognizes the non-phosphorylated motif.
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Figure 2. Normal retinocollicular mapping of L1Y1176A mutant mice
A-B. Injection of DiI into the peripheral ventro-temporal (VT) retina of WT mice (P10) 
labeled a single termination zone (TZ) in the anteromedial superior colliculus (SC) at P12.
C-D. DiI injection into the ventro-temporal retina of homozygous L1Y1229H mutant mice 
showed multiple laterally-shifted ectopic TZs (eTZs) in the anterior SC.
E-F. DiI injection into the ventro-temporal retina of homozygous L1Y1176A mutant mice 
showed only a single normal TZ in the anteromedial SC.
The position of injections is shown in flat mounts of the retina below each scheme. (L, 
lateral; M, medial; A, anterior; P, posterior; D, dorsal; V, ventral; N, nasal; T, temporal; IC, 
inferior colliculus)
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Figure 3. EphB2 kinase inhibits recruitment of ankyrin to cell membrane of L1-expression cells 
in a cytofluorescence assay
A. Immunofluorescence staining for L1 in the plasma membrane of transfected HEK293 
cells (left column, red) and EGFP-ankyrinG fluorescence (middle column, green) showed 
that EGFP-ankyrinG had a cytoplasmic distribution when expressed alone (Ankyrin), while 
L1 expression recruited EGFP-ankyrinG to the cell membrane (L1/Ankyrin). EGFP-ankyrin 
remainedG cytoplasmic when L1 was co-expressed with EphB2 (L1/Ankyrin/EphB2) but 
not with EphB2 KD (L1/Ankyrin/EphB2 KD).
Right column shows differential interference contrast (DIC) images. Scale bar=10 um
B. Quantification of percentage of cells showing ankyrin recruitment to the plasma 
membrane demonstrated that L1 increased ankyrin recruitment to the membrane in cells co-
expressing L1 and ankyrinG compared to ankyrinG alone (L1/ankyrin: 75 ± 2%; ankyrin: 18 
± 5%; one-way ANOVA, Tukey’s post-hoc test, *p<0.001).
Recruitment decreased in L1/ankyrin/EphB2 expressing cells (42 ± 6 %) compared to L1/
ankyrin (*p<0.001). There was no decrease of recruitment in L1/ankyrin/EphB2 KD (75 ± 
0.5%) compared to L1/ankyrin expressing cells. EphrinB1 treatment (35 ± 3%) reduced 
ankyrin recruitment to a small extent in L1/ankyrin expressing cells (*p<0.001). No 
significant difference was detected between ankyrin alone and negative controls of 
ankyrin/L1Y1229H (29 ± 3%), ankyrin/L1Y1229H/EphB2 (24 ± 1.5%) or ankyrin/L1Y1229H/
EphB2 + ephrinB1 (26 ± 2%) (p>0.05).
(Labeling on bars indicate cells transfected with ankyrinG alone (first bar), L1/ankyrin (L1), 
L1/ankyrin/EphB2 (L1/B2), L1/ankyrin/EphB2 KD (L1/B2 KD), L1/ankyrin/
EphB2+ephrinB1 (L1/B2+B1), L1Y1229H/ankyrin (YH), L1Y1229H/ankyrin/EphB2 (YH/
B2), L1Y1229H/ankyrin/EphB2+ephrinB1 (YH/B2+B1).
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C. L1 is phosphorylated by EphB2 at the FIGQY motif in ankyrin-expressing HEK293 cells.
Under the conditions of the ankyrin recruitment assay, EGFP-ankyrinG expressing HEK293 
cells were co-transfected with L1, L1/EphB2, L1/EphB2 KD, L1YH, or L1YH/EphB2. L1 
was immunoprecipitated from equal amounts of cell lysates (500 μg) and immunoblotted 
with p-FIGQY antibodies, then blots were stripped and reprobed with L1 antibodies. EphB2, 
but not EphB2 KD, induced L1 phosphorylation at FIGQY, while L1YH was not 
phosphorylated by EphB2.
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Figure 4. L1 FIGQY motif is phosphorylated in retina ganglion cell axons in the superior 
colliculus
A. In WT mice (P7), immunofluorescence staining for p-FIGQY (red) in sagittal sections 
through the SC co-localized in part with L1 (green) in fibers within the superficial retino-
recipient layers (SGS and SO) where RGC axons track, as indicated in merged images. P-
FIGQY staining was also seen in some fibers in the retino-recipient layers, and in deeper 
layers of the SC. No staining was detected with normal rabbit IgG. Scale bar = 200 μm. 
(SGS, stratum griseum superificiale; SO, stratum opticum; Ctx, cerebral cortex)
B. p-FIGQY antibody recognized full length L1 (220 kDa) and its principal C-terminal 
cleavage fragment (80 kDa) in the SC, as shown by immunoblotting in L1 
immunoprecipitates from WT SC lysates (P3) (upper panel). The p-FIGQY antibody also 
recognized NrCAM to a lesser extent but not CHL1 or Neurofascin (NF) 
immunoprecipitated from P3 SC (lower panel).
No bands were detected in normal mouse IgG precipitates in any sample.
C. p-FIGQY antibody did not recognize L1 immunoprecipitated from L1YH mutant SC 
(P3).
D. The relative level of p-FIGQY in full length 220 kDa L1 was decreased in L1 
immunoprecipitated from EphB2/B3 double null mutant SC (P5) compared to WT SC. 
EphB2 protein was undetectable in EphB2/B3 double mutant SC.
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Figure 5. Increased outgrowth of retinal axons from L1Y1229H mice in explants cultures from 
ventral retina
A. Quantification of mean neurite length of TuJ1-positive neurites extending from ventral 
retinal explants demonstrated that outgrowth of RGC axons from L1Y1229H mice was 
significantly greater than that of WT mice (t-test, *p<0.001). There was no significant 
difference in mean neurite length between WT dorsal and WT vental retinal explants.
n = number of mice of each genotype.
B. Ventral retina explants from L1Y1229H mutant mice showed RGC axons extending far 
from the explants edge in addition to some of comparable length compared to WT, indicated 
by immunostaining with neuronal marker TuJ1.
C. Immunostaining of ventral retinal explant cultures from WT and L1Y1229H mutant mice 
with p-FIGQY antibody showed no staining of L1YH mutant axons, while strong p-FIGQY 
staining was seen in WT axons.
Scale bar = 100 μm in B-C.
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Figure 6. Model for the regulation of L1-Ankyrin binding by ephrinB1/EphBs through tyrosine 
phosphorylation at the FIGQY domain during mouse retinocollicular targeting
During retinal ganglion cell (RGC) axon targeting in superior colliculus (SC), forward 
ephrinB1/EphB signaling recruits Src kinase to phosphorylated tyrosine residues 604/610 in 
the juxtamembrane of mouse EphB2 to induce L1-Y1229 tyrosine phosphorylation, 
potentially facilitating RGC axon growth and/or branch attraction to future termination 
zones. Reversible dephosphorylation of L1-Y1229 enables L1 to bind ankyrin through 
spectrin linkage to the actin cytoskeleton, which may promote adhesion and stabilization of 
synaptic terminals. Tyrosine Y1176 on L1 is not regulated by ephrinB1/EphB signaling and 
is dispensible for RGC axon mapping in the SC.
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